Part 1 of “Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions” is now out in the The Journal of Nuclear Medicine – JNM.

This publication looks beyond the science at what will set the pace of the field: investment flows, manufacturing capacity, supply chains and hospital readiness.

📊 MEDraysintell provided the data behind the paper’s market and investment analysis.

Our thanks to the authors, Catello Somma, Richard Zimmermann, Germo Gericke and Ken Herrmann.

Always glad to see our data support work of this calibre.

🔗 https://lnkd.in/e45cNwv3

hashtag#Radiopharmaceuticals hashtag#NuclearMedicine hashtag#RLT hashtag#MarketIntelligence hashtag#MEDraysintell